skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

(Source:Alamy)

Metformin solution, losartan tablets, ropinirole tablets and ascorbic acid tablets all more than doubled in price for certain presentations in the UK in December, according to the latest figures from WaveData.

Based on UK trade prices to independent pharmacists, WaveData calculated that the steepest average price rise came for metformin 500mg/5ml oral solution 150ml, which showed an average increase of 168% to £16.21 ($22.07), despite the cheapest offer in the market remaining unchanged at £3.84.

While the sugar-free version of the diabetes medication was granted a concession price of £40.00 by the Department of Health and Social Care in December, WaveData noted, “the data we collected for this top-spot product wasn’t described as sugar-free.” Instead, the sugar-free version actually appeared at number 13 in the market researcher’s ranking of Biggest Risers, with an average price increase of 66%.

“Of all the data we collected in December for the 50mg strength, seven prices were set above the concession and five for the 100mg,” WaveData commented, “while the 25mg faired a little better with only four above and these were all from the same wholesaler.”

Nevertheless, “we collected 14 prices made up from five different wholesalers that were pitched above that price,” WaveData commented. And while “no concession was granted for the 2mg strength, we collected six prices above the £6.51 reimbursement made up from three different wholesalers.”

Turning to our Biggest Fallers, trimethoprim 100mg tablets topped the table with an average decline of almost two-fifths to £1.50 for 28 tablets.

Other products experiencing steep price drops in December included ethosuximide capsules, prednisolone tablets and timolol eye drops, all of which saw certain presentations drop in price by more than a quarter on average.

Meanwhile, standing out among our basket of Recent Launches were vardenafil tablets that dropped in price by an average of 30% to £1.85 for four 20mg tablets, even as the cheapest offer fell by just 4% to £1.10.

Other significant movements in average prices among our Recent Launches included a 13% increase for celecoxib capsules and a 16% jump for travoprost eye drops, as well as a decline of over a fifth for nefopam tablets and rasagiline tablets falling by a tenth.

Meanwhile, focusing on the minimum prices, significantly cheaper offers could be seen for the likes of etoricoxib, frovatriptan, solifenacin and zonisamide.

Finally, our table of Fast Movers – showing those molecules with the most offers in the marketplace – reflected the dominance of omeprazole in December, followed by lansoprazole and naproxen.

 

Read also

;

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: